Chris Centeno/LinkedIn
Apr 5, 2026, 05:19
Chris Centeno: Why Regular Blood Therapy Could Boost Aging MSK Health
Chris Centeno, Chief Medical Officer of Regenexx, shared a post on LinkedIn about a recent article by Ji-Ru Cai et al, adding:
“What if you could delay aging, improve cognition, and replace old senescent cells by just giving blood every two weeks for a high-dose PRP injection somewhere in your aging MSK system?”
Read the Full Article on Aging Cell
Title: Periodic Therapeutic Phlebotomy Mitigates Systemic Aging Phenotypes by Promoting Bone Marrow Function
Authors: Ji-Ru Cai, Jian Zhang, Yue-Xin Ning, Jing Zhang, Tian-Ce Xu, Mei-Chen Liu, Ke-Xin Wang, Hui-Sheng Chen
Stay updated with Hemostasis Today.
-
Apr 4, 2026, 18:08Anirban Sen Gupta: Dante Disharoon’s Research on PlateChek Featured on JTH April 2026 Cover
-
Apr 4, 2026, 18:06Domenico Girelli: WHO 2024 Guidelines Reveal Higher Global Anemia Burden and Epidemiological Shift
-
Apr 4, 2026, 18:04Fotios Barkas: Exploring The Bidirectional Relationship Between Frailty and Stroke
-
Apr 4, 2026, 17:56Marc Turner: VETERANSFirst, CHAMPION-AF Trial, and HI-PEITHO Trial Driving Innovation at ACC26
-
Apr 4, 2026, 17:55Julian Kyoung-Ryul Chun: The Largest Dataset on Embolic Complications after AF Is Out
-
Apr 4, 2026, 17:54Marie Dragoy: Insights from Norway on Helicopter Emergency Services in Suspected Stroke Care
-
Apr 4, 2026, 17:53Julia Shapranova: Connecting Neuroscience with The Reality of Clinical Trials Leadership and Management at ESOC 2026
-
Apr 4, 2026, 17:51Filippo Cademartiri: The DECIDE Registry Tackles a Critical Gap In Cardiovascular Care
-
Apr 4, 2026, 17:51Rabiah Alnoshan: A Pactical, Bedside Focused Approach to Bleeding